Try our Advanced Search for more refined results
Life Sciences - February, 2011
176 articles
- Calif. High Court Revives Baycol Class Action
- Merck-Sanofi Animal Health Joint Venture Delayed
- 5th Circ. Vacates FDA Win On Compounded Drug Review
- Medicis, Teva Resolve Solodyn Patent Suit
- Fed. Circ. Won't Rehear Merck Temodar Patent Case
- Elan, Abbott End Ranbaxy Suit Over Generic TriCor
- Ex-Directors Of Body Armor Co. On Hook For Fraud: SEC
- Fujifilm To Buy 2 Merck Biotech Units For $490M
- French United Worker Can Sue In US: 7th Circ.
- Femina Hits Merck, Pharmacies With NuvaRing 337 Suit
- Colgate Sued Over Toothbrush Packages
- J&J Can't Shake Omnicare FCA Claims
- PDL Settles Novartis IP Row With Lucentis Payments
- A Return To The Wild West For Calif. UCL Actions
- Cephalon, Cima Sue Mylan To Block Generic Fentora
- It's A Raid! Now What?
- High Court Leaves FLSA Status Of Drug Reps Up In Air
- US Wins Fight Over $15M Drug Testing Contract
- Lilly To Pay Up To Resolve Air Emissions Suit
- Mylan Claims Fall In IP Suit Over Generic Azilect
- Bayer Sues Hexal, Salutas Over Heartburn Pill Patents
- Elan Hid Problem With $1B J&J Deal, Investors Say
- Caraco Denied Quick Win On Prandin IP Misuse Claim
- WilmerHale Scores Munger Tolles Patent Pro
- Sandoz Hit With Patent Suit Over Skin Condition Drug
- Securities Litigation Developments In 2010
- Celgene Strikes $78M Deal In Elan Abraxane IP Suit
- FDA Grants Avastin Safety Hearing For Genentech
- Fed. Circ. Reverses Radiation Therapy Patent Ruling
- Former Employee Accuses J&J Of Drug Price Fraud
- Lieff Cabraser Demands Arbitration With Partner
- Mylan Faces Patent Suits Over Generic Estradiol
- Beckman Investor Sues To Block $6.8B Danaher Deal
- Genetic Research Co. Loses Patent License Appeal
- FDA Outlines Initiatives Inspired By DES 'Tragedy'
- Researcher Sues CVS For Prescription Data
- Endo Can't Shake Claims In Roche Generic Valcyte Suit
- WilmerHale Reps Thermo Fisher In $940M Unit Sales
- Medicines Co. Sues Mylan Over Generic Angiomax
- Genentech Used IP To Form $1B Monopoly, HGS Says
- House Urges FDA To Find Contaminated Heparin Source
- Latham Reps Silverfleet In $675M Sterigenics Sale
- Fed. Circ. Knocks Down $1.7B Humira Patent Verdict
- NY Nets $2.5M In Settlement With Pfizer Subsidiary
- Ex-CEO Stole Trade Secrets, Drug Co. Says
- Roxane Agrees To Delay Launch Of Generic Asacol
- Pfizer Ends Suits Over Nigerian Trovan Deaths
- Philips Reports Possible FCPA Violations
- Sun Pharma Buys Out Remainder Of Caraco
- Spain's Antitrust Watchdog Fines Perfume Group $1.2M
- High Court Won't Review $5B Vioxx Deal
- Ex-Bristol Myers Worker Gets Time Served For IP Theft
- High Court Says Vaccine Act Preempts State Law Claims
- Covington Reps Forest Labs In $1.2B Clinical Data Deal
- Chem Rx Claims Former Exec Lured Clients To Rival
- FCA Liability In A Post-PPACA World
- Dissecting ALI's Restatement Of Torts
- BNLfood Sues Martek Over Access To US Market
- Covidien Faces Class Action Over Off-The-Clock Work
- Zimmer Hits Law Firms With False Advertising Suit
- 11th Circ. Upholds Helvetia Fraudster's Conviction
- Watson's Generic Mucinex Doesn't Infringe, Judge Says
- Biovail Founder Strikes Deal In SEC Fraud Suit
- Abbott Hits Sandoz With New Niaspan Patent Suit
- NZ Bans Avandia Over Cardiovascular Concerns
- Taming The Wild West Of IP Protection
- Sanofi Wins Injunction In Sun IP Suit Over Eloxatin
- Feds Charge 114 In Massive Medicare Fraud Crackdown
- Judge Disses Class Cert. Bid In Sanofi Ketek Suit
- Volcano Ordered To Pay $5M In LightLab Laser Fight
- Senate Bill Aims To Restrict Authorized Generics
- Microsoft, Therasense And Burdens Of Proof
- FDA Issues Recall Of Medtronic Infusion Pumps
- Abbott, Fournier Drop Suit Over Generic TriCor
- Class Action Over Guidant Pacemakers Nixed
- PDL To Pay MedImmune $93M In IP Suit Over Synagis
- La. Seeks $12B In Avandia Medicaid Fraud Suit
- J&J Unit Recalls Antipsychotic Syringes Over Cracks
- Leo Pharma Sues Perrigo Israel Over Generic Taclonex
- Novo Nordisk Faces Criminal Probe Over Diabetes Drugs
- Brothers Plead Guilty To Insider Trading At Sequenom
- Weber Can't Shake Grill False Marking Suit
- Compelling Disgorgement In Antitrust Cases
- Sanofi Bags Genzyme With Incentive-Laden $20B Offer
- Sidley Austin Snags Ex-Inspector General For Chicago
- Quigley To Meet Deadline Or Face Asbestos Claims
- Valeant Must Share In Lilly Defense Costs, Judge Says
- High-Risk Recalls Have Weaker Approval Process: Study
- Inspire Settles AzaSite False Marking Suit
- Q-Med Pays To Shut Down Genzyme Injection IP Fight
- $3.6M Hemispherx Securities Settlement Gets Final OK
- PIC Loses Claim Construction Bid In DNA Patent Suit
- Recalled Triad Products Blamed For Child's Death
- Drug Sales Reps Exempt From OT, 9th Circ. Rules
- Bowman Expands Pharma Practice In New Austin Office
- Obama Takes Aim At Pay-For-Delay In 2012 Budget
- Merck Wins 1st State Fosamax Trial In NJ
- Fed. Circ. Won't Reinstate Lapsed University Patent
- Senate Bill Would Ease Drug Imports, Boost Inspection
- Fed. Circ. Won't Rescue Hako-Med Patent Verdict
- False Marking Suits More Bark Than Bite, Stats Show
- MoFo Snags 2 Attys From Alston, Wilson Sonsini
- Listerine Marketing Actions Consolidated In Fla.
- Pharma/Device Enforcement: A Year In Review
- Looking Back At Employment Litigation In 2010
- AstraZeneca Targets Korean Co. Over Nexium Patents
- Sun Pharma Freezes Generic Eloxatin Sales
- Novartis Says Mylan Infringed Lescol Patent
- Judge Approves Blood Plasma Antitrust MDL
- Calif. Appeals Court Lets J&J Motrin Suit Proceed
- Brazil Orders Shell To Divest Fuel Biz In $12B Venture
- Ex-Greenberg Traurig Atty Appointed CardioNet GC
- Q-Med Board Endorses Galderma's Sweetened Bid
- Squire Sanders Adds Jones Day Life Sciences Atty
- Ex-Paul Hastings Atty Pays To Settle SEC Suit
- Danisco Can't Shake Enzyme Patent Suit
- ArthroCare Strikes Deal To End SEC Accounting Probe
- Retail Reps Hit Crossmark With Overtime Action
- Omnicare V. UnitedHealth And Independent Action
- Sunshine Bill Aims To Restrict Court Secrecy Orders
- Elan Shareholder Suit Gets The Boot
- Lilly Asks High Court To Review Double Patenting
- EU Court Revives Ineos Bid For AlphaRen Mark
- House GOP Calls For Deep FY 2011 Budget Cuts
- Drinker Biddle Picks Up Dechert Dealmaker
- DLA Piper Lures 2 Paul Hastings Litigation Leaders
- King & Spalding Lands 14-Lawyer Filice Brown Team
- J&J, Plaintiffs Seek Arbitration In Sutures MDL
- House Bill Targets Learned Intermediary Defense
- JPML Won't Combine Boehringer Sales Reps' OT Suits
- WilmerHale Snags Silicon Valley IP Pro From Howrey
- Edwards Keeps $74M Award In CoreValve Patent Suit
- Pfizer Appeals Sanctions In Neurontin Antitrust Action
- UMass Gets Unfair Enrichment Claim Nixed In IP Suit
- NC Dental Board Not Immune From Antitrust Law: FTC
- Galderma's $978M Bid Falls Short With Q-Med Investors
- FDA To Fast-Track High-Tech Medical Devices
- Pa. Court Reinstates $10M Verdict In Prempro Suit
- Natco Challenges Gilead Science's Tamiflu Patent
- Judge Orders 2 More Bellwethers In Fosamax MDL
- UCB To Pay PDL $10M Over Antibody Patents
- Lathrop & Gage Targets Biotech With Boston Office
- Square Peg, Round Hole: Product Defects And The FCA
- Attorneys Seek $22M In Fees For Pfizer Settlement
- Ex-GSK Atty Wants Obstruction Charge Nixed
- 9th Circ. Shuts Down Sequus Medical Licensing Spat
- Judge Pushes To Nix 215 Plaintiffs In Neurontin MDL
- Cell Therapeutics Fails To Nix Investor Class Action
- GSK Tightens Avandia Restrictions
- Wachtell Reps Danaher In $6.8B Beckman Coulter Deal
- When To Push For A Determination Under Riegel
- Lobbying Spending Growth Flat For 1st Time In Decade
- AvMed Brings Veteran Atty Ziegler In House
- MDL Panel Won't Consolidate Infested Formula Actions
- Health Net Hits Solvay With AndroGel Antitrust Action
- American, UPS Hit With Data Encryption IP Suits
- States Can Cut Costs Without Medicaid Waivers: HHS
- 3 Staffers Hit Hologic With Overtime Action
- UnitedHealth Wants GSK Paxil Case Back In State Court
- Investors Slam MannKind After FDA Balks On Afrezza
- Lupin Sues Paddock Over Generic Antara
- Case Study: White V. Wyeth
- Somaxon Hits Par With IP Suit Over Silenor Generic
- Metabolite Can't Have Cake, Eat It Too: 10th Circ.
- Law360 Corporate Finance Editorial Advisory Board
- Law360 Intellectual Property Editorial Advisory Board
- Australian Judge Allows Sale Of Generic Taxotere
- US To Join FCA Action Against Abbott Over Depakote
- ITC To Investigate Birthing Dolls From China
- Watson Settles Androderm False Marking Suit
- Avastin Plus Chemo Equals Higher Death Risk: Study
- Actavis Ordered To Pay $170M In Medicaid Fraud Suit
- Genzyme Seeks Toss Of Investors' Insider Trading Suit
- Wyeth Loses Bid To Stay Stent Patent Dispute
- Drug Co. Valeant To Snap Up PharmaSwiss For $484M
- Direct Purchasers' Plavix Antitrust Actions Tossed